Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Jun 11, 2024
Net Buying
Open-Market Buys
$381K
Open-Market Sells
$0
Net Open-Market Flow
$381K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2024Buy(P)86K$0.94$81K1.7M
Jun 7, 2024Buy(P)319K$0.94$300K1.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-051866) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML